Clinical Trials Browser

Phase NA × Recurrence × lenvatinib × Clear all

NCT07077798 2025-07-22

Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection

Phase NA Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence